Influence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, Brazil

Human papillomavirus (HPV) infections are strongly associated with the development of cervical intraepithelial neoplasias and invasive cervical cancer. Polymorphisms in cytokine-encoding genes and behavioural cofactors could play an important role in protecting an individual against viral infections and cancer. Here, we investigated whether IL-6 -174 G>C, IL-8 +396 G>T, and TGF-β1 +869 G>C and +915 G>C polymorphisms were associated with susceptibility to HPV infection in women from north-east (Pernambuco) Brazil. We analysed 108 healthy uninfected women (HC) and 108 HPV-positive women with cervical lesions. Genetic polymorphisms were assessed using Sanger sequencing and polymerase chain reaction-restriction fragment length polymorphism. Comparison of the distribution of the genotypic and allelic frequencies of the IL-18 +396 T>G polymorphism between HPV infected woman an uninfected controls showed that the GG genotype and G allele were both more frequent in the HC group, and were associated with protection from HPV infection (p = 0.0015; OR = 0.29 CI95% = 0.13-0.61; p = 0.0005; OR = 0.45 CI95% 0.29-0.7, respectively). Individuals from the control group could have previously had HPV infection that was spontaneously eliminated; however, it was undetectable at the time of sample collection. Based on our findings, we hypothesize that the IL-8 +396 G>T polymorphism could interfere with susceptibility to HPV infection, by modulating the ability of immune system to fight the virus.

[1]  Hong Li,et al.  Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. , 2015, Oncology letters.

[2]  R. Guimarães,et al.  A rapid screening of ancestry for genetic association studies in an admixed population from Pernambuco, Brazil. , 2015, Genetics and molecular research : GMR.

[3]  C. Struchiner,et al.  Pharmacogenomic implications of population admixture: Brazil as a model case. , 2014, Pharmacogenomics.

[4]  A. Sell,et al.  The Association of the Immune Response Genes to Human Papillomavirus-Related Cervical Disease in a Brazilian Population , 2013, BioMed research international.

[5]  Duane H. Hamilton,et al.  Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. , 2012, Future oncology.

[6]  X. Zhang,et al.  Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion. , 2012, Cytokine.

[7]  Hong Chen,et al.  Association between cytokine gene polymorphisms and cervical cancer in a Chinese population. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[8]  A. Hildesheim,et al.  Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection. , 2011, Cytokine.

[9]  C. Akdis,et al.  Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. , 2011, The Journal of allergy and clinical immunology.

[10]  E. Donadi,et al.  A pilot case-control association study of cytokine polymorphisms in Brazilian women presenting with HPV-related cervical lesions. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[11]  P. Brennan,et al.  Lack of Association between −251 T>A Polymorphism of IL8 and Lung Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[12]  Erwin G. Van Meir,et al.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. , 2005, Neuro-oncology.

[13]  Gerard C Blobe,et al.  Role of transforming growth factor Beta in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Chanock,et al.  Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  S. Kassim,et al.  Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. , 2004, Clinical biochemistry.

[16]  Allan Hildesheim,et al.  Chapter 5: Viral and host factors in human papillomavirus persistence and progression. , 2003, Journal of the National Cancer Institute. Monographs.

[17]  J. Chang-Claude,et al.  A Transforming Growth Factorβ1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer , 2003 .

[18]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[19]  G. Stanczuk,et al.  Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta1) gene in patients with invasive squamous cell carcinoma of the uterine cervix. , 2002, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[20]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[21]  D. Kwiatkowski,et al.  Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. , 2001, American journal of human genetics.

[22]  S. Paludan,et al.  Molecular Pathways in Virus-Induced Cytokine Production , 2001, Microbiology and Molecular Biology Reviews.

[23]  Y. Horiguchi,et al.  Serum interleukin 6 as a prognostic factor in patients with prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  C. Miki,et al.  Serum interleukin‐6 level reflects the tumor proliferative activity in patients with colorectal carcinoma , 1999, Cancer.

[25]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[26]  G. Johnson,et al.  Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Levine,et al.  p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[29]  E. Martinelli,et al.  Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.